Understanding the formula protects you from dosing errors
NHS treatment is typically limited to a maximum of 2 years, making it essential to establish long-term dietary and physical activity habits during treatment to support weight maintenance afterwards

Before starting GLP-1 medications: Ensure you've had a recent diabetic eye screening (within the past 12 months) Discuss your retinopathy status with your prescribing clinician If you have known retinopathy, consider ophthalmology review before initiation Understand that gradual dose titration may help avoid very rapid changes in blood glucose, which is a general principle in diabetes management During treatment: Attend all scheduled diabetic eye screening appointments without fail If you have pre-existing retinopathy, your diabetes team may consider more frequent monitoring based on your individual clinical situation Control blood pressure to target levels (below 140/90 mmHg, or below 130/80 mmHg if you have kidney, eye or cerebrovascular damage, if tolerated) [13] Maintain good overall glycaemic control whilst avoiding excessively rapid HbA1c reductions when possible Stop smoking if applicable, as tobacco significantly worsens diabetic eye disease Manage cholesterol levels according to NICE guidance for cardiovascular risk reduction Communicate openly with your healthcare team about any visual symptoms, even if they seem minor

Signs include strong pain in the upper belly, chills, and vomiting that does not stop
Trials of this class of medication have shown it can help users shed 10% the o 15% of their total body weight and this news has started a frenzy among those who have been unsuccessful lifetime dieters
GI side-effect profiles were broadly similar